0001209191-23-027770.txt : 20230505 0001209191-23-027770.hdr.sgml : 20230505 20230505170301 ACCESSION NUMBER: 0001209191-23-027770 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230503 FILED AS OF DATE: 20230505 DATE AS OF CHANGE: 20230505 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Judice Kevin CENTRAL INDEX KEY: 0001638944 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40794 FILM NUMBER: 23894849 MAIL ADDRESS: STREET 1: 6310 NANCY RIDGE DRIVE CITY: SAN DIEGO STATE: CA ZIP: 92121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: DICE Therapeutics, Inc. CENTRAL INDEX KEY: 0001645569 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 472286244 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 400 EAST JAMIE COURT STREET 2: SUITE 300 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 650-566-1402 MAIL ADDRESS: STREET 1: 400 EAST JAMIE COURT STREET 2: SUITE 300 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 FORMER COMPANY: FORMER CONFORMED NAME: DiCE MOLECULES HOLDINGS, LLC DATE OF NAME CHANGE: 20180725 FORMER COMPANY: FORMER CONFORMED NAME: DiCE Molecules Holdings, LLC DATE OF NAME CHANGE: 20150617 4 1 doc4.xml FORM 4 SUBMISSION X0407 4 2023-05-03 0 0001645569 DICE Therapeutics, Inc. DICE 0001638944 Judice Kevin C/O DICE THERAPEUTICS, INC. 400 EAST JAMIE COURT, SUITE 300 SOUTH SAN FRANCISCO CA 94080 1 1 0 0 CEO 0 Common Stock 2023-05-03 4 S 0 13698 36.50 D 799685 D The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on October 28, 2022. /s/ Scott Robertson as attorney-in-fact for J. Kevin Judice 2023-05-05